Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McMaster University

$50,000.00

Integrative strategies for metabolomic analyses by capillary electrophoresis

FY 2009-10

Summary
Metabolomics represents an emerging field of functional genomic research that has promising applications in drug discovery and disease prognosis. Capillary electrophoresis (CE) offers a versatile format for metabolomic analyses, which can also be used to study protein-drug interactions in free solution. Our group is interested in developing fully integrated strategies for metabolomics which combine sample pretreatment with chemical analysis in a single-step. This offers the benefit of a rapid, automated and sensitive format for metabolite analysis not feasible by conventional chromatographic or spectroscopic techniques. The long-term goals of this research proposal address three major obstacles confronting current metabolomic initiatives. The first project is focused on developing quantitative models for accurate prediction of the relative migration time and relative ion response of metabolites based on their putative chemical structure using CE-mass spectrometry (MS) with computer modeling. This will provide an improved strategy for identification and quantification of unknown metabolites in biological samples that is relevant to universal newborn screening programs for early detection of in-born errors of metabolism. The second project will develop a label-free method for high quality screening of drug candidates for targeted protein by CE. This work will provide deeper insight into the biological activity of putative drugs based on their impact on protein conformational stability. The last project is aimed at developing low-cost yet selective assays for routine screening of sugar metabolic disorders in biological samples without off-line sample pretreatment. Our research program in metabolomics is unique in Canada that is based on both fundamental and applied aspects of chemical research that will have major impacts for disease prevention, early intervention and drug treatment.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
298422-2009
Name nom
BritzMcKibbin, Philip
Department département
Chemistry
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
50000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
26
Committee name en
Anal. & Phys. Chemistry
Committee name fr
Chimie analytique et physique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3503
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Separation methods
Research subject fr
Méthodes de séparation
Partie
1
Nb partie
5
Application title
Integrative strategies for metabolomic analyses by capillary electrophoresis
Keyword
NA
Application summary
Metabolomics represents an emerging field of functional genomic research that has promising applications in drug discovery and disease prognosis. Capillary electrophoresis (CE) offers a versatile format for metabolomic analyses, which can also be used to study protein-drug interactions in free solution. Our group is interested in developing fully integrated strategies for metabolomics which combine sample pretreatment with chemical analysis in a single-step. This offers the benefit of a rapid, automated and sensitive format for metabolite analysis not feasible by conventional chromatographic or spectroscopic techniques. The long-term goals of this research proposal address three major obstacles confronting current metabolomic initiatives. The first project is focused on developing quantitative models for accurate prediction of the relative migration time and relative ion response of metabolites based on their putative chemical structure using CE-mass spectrometry (MS) with computer modeling. This will provide an improved strategy for identification and quantification of unknown metabolites in biological samples that is relevant to universal newborn screening programs for early detection of in-born errors of metabolism. The second project will develop a label-free method for high quality screening of drug candidates for targeted protein by CE. This work will provide deeper insight into the biological activity of putative drugs based on their impact on protein conformational stability. The last project is aimed at developing low-cost yet selective assays for routine screening of sugar metabolic disorders in biological samples without off-line sample pretreatment. Our research program in metabolomics is unique in Canada that is based on both fundamental and applied aspects of chemical research that will have major impacts for disease prevention, early intervention and drug treatment.